Back to mobile site

Signal Genetics (SGNL) Enters Agreement with MD Anderson Cancer Center

January 6, 2016 8:31 AM EST Send to a Friend
Signal Genetics, Inc. (NASDAQ: SGNL) announced that the Company has entered into an agreement with the University of Texas MD ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login